Immucor Inc BLUD agreed to be bought by TPG Capital in a deal worth $1.97 billion or $27 per share in cash..
The price represents a 30% premium over BLUD's closing share price on July 1. The transaction is likely to close in the second half of this year. The deal was unanimously approved by the Immucor board of directors.
BLUD shares gained 1.52% to close at $20.73 on Friday.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in